Labaton Sucharow LLP Files Securities Class Action Lawsuit Against Everbridge, Inc.
NEW YORK–(BUSINESS WIRE)–Labaton Sucharow LLP (“Labaton Sucharow”) announces that on April 4, 2022, it filed…
Month: April 2022
Drones Are the New First Responders
By Dr. Shaun Passley In terms of sheer versatility, it’s hard to imagine an invention…
Supernus Provides Update on Filing of Annual Report and Reiterates Full Year 2022 Financial Guidance
Annual Report on Form 10-K for fiscal year ended December 31, 2021 to be filed…
AGTC to Showcase Interim Findings from Ongoing XLRP and Achromatopsia Phase 1/2 Trials at the Association for Research in Vision and Ophthalmology 2022 Annual Meeting
GAINESVILLE, Fla., and CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) today…
New Data at AAN 2022 Highlight Real-World Evidence from Biogen’s MS Portfolio and Emerging Research on Disease Progression
Data from NOVA study further support the efficacy and safety of natalizumab IV when administered…
Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules Capital
WALTHAM, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…
Terns Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
FOSTER CITY, Calif., April 04, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Vir Biotechnology to Participate in the 21st Annual Needham Healthcare Conference
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
4D Molecular Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of 4D-710, an A101 AAV Vector-based, Aerosol-delivered Genetic Medicine for the Treatment of Cystic Fibrosis
EMERYVILLE, Calif., April 04, 2022 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (4DMT) (Nasdaq: FDMT),…
Nurix Therapeutics Announces Participation in the 21st Annual Needham Virtual Healthcare Conference
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage…
Kala Pharmaceuticals to Present Phase 1b Clinical Data for KPI-012 in Patients with PCED at 2022 ARVO Annual Meeting
ARLINGTON, Mass., April 04, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical…
Freeline Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON, April 04, 2022 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company”…
Cara Therapeutics Announces Biomarker Data from KALM-1 and KALM-2 Trials of KORSUVA™ (difelikefalin) Injection Selected for Presentation at National Kidney Foundation Spring Clinical Meetings 2022
Poster highlights reduction in itch intensity with difelikefalin treatment correlated with reductions in inflammatory markers…
Neurona Therapeutics to Present at the Locust Walk Stem Cell Tx Conference
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) — Neurona Therapeutics, a clinical-stage biotherapeutics company advancing…
Mercury announces new line of drop-in radiation-tolerant power supplies for the Space market
Standardized ultra-compact FPGA power module enables the most demanding on-orbit processing Mercury’s RH5210 Power Module…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Lucid Group, Inc. (LCID) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Beaverton School District Benefits from PowerSchool Solutions for Optimized K-12 Enterprise Resource Planning
Oregon school district sees improvements to finance, human resource, and payroll operations by implementing PowerSchool…
iLearningEngines Acquires in2vate
The acquisition accelerates iLearningEngines’ go to market plans and leadership in AI driven learning automation…
New Mountain Finance Corporation Schedules its First Quarter 2022 Earnings Release and Dividend Announcement
NEW YORK–(BUSINESS WIRE)–New Mountain Finance Corporation (Nasdaq: NMFC) (“NMFC” or “the Company”) today announced that…